Elevation Oncology, Inc. (Nasdaq:ELEV)

Health Care/Life Sciences • Biotechnology

CIK 1783032

Company

Elevation Oncology, Inc. is a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.

Address
101 Federal Street
12th floor
Boston, Massachusetts 02110

Employees
33

Stock Info

Close
$4.6700

Day Range
4.5000 - 5.5000

52 Week Range
0.3630 - 5.8900

Average volume
2.77M

Short Interest
4.01M (02/15/24)

% of Float Shorted
11.55%

Market Cap
$204.01M

Revenue
N/A

Net Income
-$95.08M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$2.1569

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Joseph J Ferra Jr., MBA

Board Director
Lori Hu MBA

Chairman
Steven Arnote Elms MBA

Independent Director
Darcy Mootz PhD

Independent Director
R Michael Carruthers MBA

Independent Director
Timothy P Clackson PhD

SEC filings

Date	Form	Event
18 Dec, 2024	4
19 Nov, 2024	4
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
12 Nov, 2024	SC 13G/A
12 Nov, 2024	SC 13G/A
8 Nov, 2024	SC 13G/A
6 Nov, 2024	SC 13G
6 Nov, 2024	8-K
6 Nov, 2024	10-Q
4 Nov, 2024	SC 13G/A
9 Oct, 2024	SC 13G/A
20 Sep, 2024	8-K
18 Sep, 2024	4
19 Aug, 2024	4
15 Aug, 2024	SC 13G
8 Aug, 2024	SC 13D/A
6 Aug, 2024	8-K
6 Aug, 2024	10-Q
15 Jul, 2024	SC 13G/A
18 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
17 Jun, 2024	4
14 Jun, 2024	8-K
17 May, 2024	4
9 May, 2024	424B3
9 May, 2024	EFFECT
7 May, 2024	CORRESP
7 May, 2024	UPLOAD
2 May, 2024	S-3
2 May, 2024	10-Q
2 May, 2024	8-K
26 Apr, 2024	DEF 14A
26 Apr, 2024	DEFA14A
26 Apr, 2024	ARS
9 Apr, 2024	SC 13G
5 Apr, 2024	8-K
19 Mar, 2024	4
6 Mar, 2024	S-8
6 Mar, 2024	10-K
6 Mar, 2024	8-K
4 Mar, 2024	3
4 Mar, 2024	3
4 Mar, 2024	4
4 Mar, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
20 Feb, 2024	4
14 Feb, 2024	SC 13G
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
7 Feb, 2024	SC 13G/A
6 Feb, 2024	SC 13G/A
31 Jan, 2024	SC 13G/A
23 Jan, 2024	8-K
22 Jan, 2024	SC 13G
22 Jan, 2024	8-K
22 Jan, 2024	SC 13G
22 Jan, 2024	4
22 Jan, 2024	3
9 Jan, 2024	SC 13G/A
9 Jan, 2024	SC 13G
5 Jan, 2024	8-K
19 Dec, 2023	4
2 Nov, 2023	10-Q
2 Nov, 2023	8-K
22 Sep, 2023	8-K
19 Sep, 2023	4
5 Sep, 2023	4
16 Aug, 2023	8-K
3 Aug, 2023	10-Q
3 Aug, 2023	8-K
3 Aug, 2023	424B5
13 Jul, 2023	8-K	CEO Change
21 Jun, 2023	4
21 Jun, 2023	4
21 Jun, 2023	4
21 Jun, 2023	4
21 Jun, 2023	4
21 Jun, 2023	4
15 Jun, 2023	SC 13D/A
9 Jun, 2023	424B5
9 Jun, 2023	SC 13G
9 Jun, 2023	8-K
8 Jun, 2023	424B5
8 Jun, 2023	SC 13G
5 Jun, 2023	8-K
24 May, 2023	SC 13G
15 May, 2023	8-K
15 May, 2023	10-Q
27 Apr, 2023	ARS
27 Apr, 2023	DEFA14A
27 Apr, 2023	DEF 14A
17 Apr, 2023	8-K
14 Apr, 2023	PRE 14A
20 Mar, 2023	4
9 Mar, 2023	S-8
9 Mar, 2023	8-K
9 Mar, 2023	10-K
3 Mar, 2023	8-K
24 Feb, 2023	SC 13G
17 Feb, 2023	4
17 Feb, 2023	4
17 Feb, 2023	4
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
8 Feb, 2023	SC 13G/A
10 Jan, 2023	4
10 Jan, 2023	4
10 Jan, 2023	4
6 Jan, 2023	8-K	CEO Change
19 Dec, 2022	4
3 Nov, 2022	10-Q
3 Nov, 2022	8-K
30 Sep, 2022	SC 13G
26 Sep, 2022	SC 13D/A
4 Aug, 2022	EFFECT
4 Aug, 2022	10-Q
4 Aug, 2022	424B5
4 Aug, 2022	8-K
2 Aug, 2022	S-3/A
2 Aug, 2022	CORRESP
28 Jul, 2022	8-K
11 Jul, 2022	SC 13G/A
6 Jul, 2022	UPLOAD
1 Jul, 2022	S-3
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
22 Jun, 2022	4
21 Jun, 2022	8-K
10 Jun, 2022	SC 13G/A
27 May, 2022	4
27 May, 2022	SC 13D/A
27 May, 2022	8-K
5 May, 2022	10-Q
5 May, 2022	8-K
29 Apr, 2022	DEF 14A
29 Apr, 2022	DEFA14A
16 Mar, 2022	3
16 Mar, 2022	4
3 Mar, 2022	8-K
3 Mar, 2022	10-K
3 Mar, 2022	S-8
16 Feb, 2022	4
16 Feb, 2022	4
16 Feb, 2022	4
14 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G
8 Feb, 2022	SC 13G
21 Jan, 2022	8-K
18 Jan, 2022	SC 13G
12 Nov, 2021	10-Q
12 Nov, 2021	8-K
21 Oct, 2021	4
21 Oct, 2021	3
12 Aug, 2021	10-Q
12 Aug, 2021	8-K
6 Aug, 2021	8-K
9 Jul, 2021	SC 13D
9 Jul, 2021	SC 13G
9 Jul, 2021	SC 13G
1 Jul, 2021	4
1 Jul, 2021	4
1 Jul, 2021	4
1 Jul, 2021	4
29 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
28 Jun, 2021	4
25 Jun, 2021	424B1	IPO completed
25 Jun, 2021	S-8
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	SEC STAFF
24 Jun, 2021	CORRESP
24 Jun, 2021	CORRESP
24 Jun, 2021	EFFECT
24 Jun, 2021	CERT
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
24 Jun, 2021	3
23 Jun, 2021	S-1/A
23 Jun, 2021	CORRESP
23 Jun, 2021	UPLOAD
21 Jun, 2021	CORRESP
21 Jun, 2021	8-A12B
21 Jun, 2021	S-1/A
16 Jun, 2021	S-1/A
16 Jun, 2021	UPLOAD
11 Jun, 2021	CORRESP
7 Jun, 2021	CORRESP
4 Jun, 2021	S-1
27 May, 2021	SEC STAFF
27 May, 2021	UPLOAD
14 May, 2021	DRS/A
14 May, 2021	DRSLTR
7 May, 2021	UPLOAD
9 Apr, 2021	DRS

Last update:2024-03-06 13:27:43.996099

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.